STOCK TITAN

[SCHEDULE 13G] Solventum Corporation SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G
Rhea-AI Filing Summary

Solventum Corporation received a Schedule 13G disclosure from Independent Franchise Partners, LLP, a United Kingdom investment adviser, reporting beneficial ownership of 10,141,066 common shares, representing 5.86% of the outstanding class. The filing covers the issuer's common stock and identifies the reporting person as an IA (investment adviser).

The statement shows sole voting power over 10,011,852 shares and sole dispositive power over 10,141,066 shares, and includes a certification that the shares are held in the ordinary course of business and not for the purpose of changing or influencing control. The disclosure notifies investors of a passive, material stake above the 5% reporting threshold.

Solventum Corporation ha ricevuto una comunicazione Schedule 13G da Independent Franchise Partners, LLP, un consulente di investimento del Regno Unito, che riporta la titolarità effettiva di 10.141.066 azioni ordinarie, pari al 5,86% della classe in circolazione. La comunicazione riguarda le azioni ordinarie dell'emittente e identifica il soggetto segnalante come IA (investment adviser).

Dalla dichiarazione risulta il potere di voto esclusivo su 10.011.852 azioni e il pieno potere di disposizione su 10.141.066 azioni; è inoltre certificato che le azioni sono detenute nell'ordinario corso dell'attività e non con l'intento di modificare o influenzare il controllo. La disclosure informa gli investitori di una partecipazione materiale e passiva oltre la soglia di segnalazione del 5%.

Solventum Corporation recibió un formulario Schedule 13G de Independent Franchise Partners, LLP, un asesor de inversiones del Reino Unido, que informa la titularidad beneficiaria de 10.141.066 acciones ordinarias, que representan el 5,86% de la clase en circulación. La presentación cubre las acciones ordinarias del emisor e identifica al declarante como IA (investment adviser).

La declaración muestra poder de voto exclusivo sobre 10.011.852 acciones y poder de disposición exclusivo sobre 10.141.066 acciones, e incluye una certificación de que las acciones se mantienen en el curso normal del negocio y no con el propósito de cambiar o influir en el control. La divulgación notifica a los inversores sobre una participación material y pasiva por encima del umbral de reporte del 5%.

Solventum Corporation는 영국의 투자자문사 Independent Franchise Partners, LLP로부터 Schedule 13G 공시를 받았으며, 해당 회사가 10,141,066주의 보통주를 실소유하고 있어 전체 발행주식의 5.86%를 차지한다고 보고했습니다. 이 제출서는 발행회사의 보통주를 대상으로 하며 신고자를 IA(investment adviser)로 식별합니다.

신고서에는 10,011,852주에 대한 단독 의결권과 10,141,066주에 대한 단독 처분권이 명시되어 있으며, 해당 주식이 영업의 정상적인 범위 내에서 보유되고 있고 지배권을 변경하거나 영향력을 행사하기 위한 목적이 아님을 인증하고 있습니다. 이 공시는 5% 보고 기준을 초과하는 수동적이면서 중요한 지분 보유를 투자자에게 알립니다.

Solventum Corporation a reçu une déclaration Schedule 13G de la part d'Independent Franchise Partners, LLP, un conseiller en investissement du Royaume-Uni, déclarant la propriété bénéficiaire de 10 141 066 actions ordinaires, représentant 5,86% de la classe en circulation. Le dépôt couvre les actions ordinaires de l'émetteur et identifie la personne déclarante comme IA (investment adviser).

La déclaration indique un pouvoir de vote exclusif sur 10 011 852 actions et un pouvoir de disposition exclusif sur 10 141 066 actions, et comprend une certification selon laquelle les actions sont détenues dans le cours normal des affaires et non dans le but de changer ou d'influencer le contrôle. La communication informe les investisseurs d'une participation matérielle et passive supérieure au seuil de déclaration de 5%.

Solventum Corporation hat eine Schedule 13G-Meldung von Independent Franchise Partners, LLP, einem Investmentberater aus dem Vereinigten Königreich, erhalten, die die wirtschaftliche Eigentümerschaft von 10.141.066 Stammaktien meldet, was 5,86% der ausstehenden Klasse entspricht. Die Einreichung betrifft die Stammaktien des Emittenten und identifiziert den Melder als IA (investment adviser).

Die Erklärung weist ein alleiniges Stimmrecht für 10.011.852 Aktien und ein alleiniges Verfügungsrecht für 10.141.066 Aktien aus und enthält eine Bestätigung, dass die Aktien im gewöhnlichen Geschäftsgang gehalten werden und nicht mit dem Ziel, die Kontrolle zu ändern oder zu beeinflussen. Die Offenlegung informiert Anleger über eine passive, materielle Beteiligung oberhalb der Meldegrenze von 5%.

Positive
  • Material disclosure: Reported beneficial ownership of 10,141,066 shares (5.86%), exceeding the 5% reporting threshold.
  • Concentrated control: Reporting person states sole voting power over 10,011,852 shares and sole dispositive power over 10,141,066 shares.
Negative
  • None.

Insights

TL;DR: A material passive stake (5.86%) reported; ownership provides sole voting and dispositive control without declared intent to change control.

The filing shows Independent Franchise Partners holds 10,141,066 shares, equal to 5.86% of Solventum's common stock, which crosses the material 5% reporting threshold that often draws investor attention. The holder reports sole voting power for 10,011,852 shares and sole dispositive power for 10,141,066 shares, indicating concentrated economic and voting exposure. Because the filing is a Schedule 13G with a certification of passive intent, the immediate governance implications are limited, but the position is large enough to matter for future disclosures or activism if intentions change.

TL;DR: Ownership is material but reported as passive; no current indication of activist intent or group affiliation.

Independent Franchise Partners is identified as an investment adviser and reports sole voting/dispositive powers for the majority of its stake. The Schedule 13G pathway and the included certification assert the holdings are in the ordinary course and not intended to influence control, reducing immediate governance concern. Nevertheless, any future conversion to a Schedule 13D or coordination with others would materially alter the governance outlook. For now, this is a notable but neutral governance development.

Solventum Corporation ha ricevuto una comunicazione Schedule 13G da Independent Franchise Partners, LLP, un consulente di investimento del Regno Unito, che riporta la titolarità effettiva di 10.141.066 azioni ordinarie, pari al 5,86% della classe in circolazione. La comunicazione riguarda le azioni ordinarie dell'emittente e identifica il soggetto segnalante come IA (investment adviser).

Dalla dichiarazione risulta il potere di voto esclusivo su 10.011.852 azioni e il pieno potere di disposizione su 10.141.066 azioni; è inoltre certificato che le azioni sono detenute nell'ordinario corso dell'attività e non con l'intento di modificare o influenzare il controllo. La disclosure informa gli investitori di una partecipazione materiale e passiva oltre la soglia di segnalazione del 5%.

Solventum Corporation recibió un formulario Schedule 13G de Independent Franchise Partners, LLP, un asesor de inversiones del Reino Unido, que informa la titularidad beneficiaria de 10.141.066 acciones ordinarias, que representan el 5,86% de la clase en circulación. La presentación cubre las acciones ordinarias del emisor e identifica al declarante como IA (investment adviser).

La declaración muestra poder de voto exclusivo sobre 10.011.852 acciones y poder de disposición exclusivo sobre 10.141.066 acciones, e incluye una certificación de que las acciones se mantienen en el curso normal del negocio y no con el propósito de cambiar o influir en el control. La divulgación notifica a los inversores sobre una participación material y pasiva por encima del umbral de reporte del 5%.

Solventum Corporation는 영국의 투자자문사 Independent Franchise Partners, LLP로부터 Schedule 13G 공시를 받았으며, 해당 회사가 10,141,066주의 보통주를 실소유하고 있어 전체 발행주식의 5.86%를 차지한다고 보고했습니다. 이 제출서는 발행회사의 보통주를 대상으로 하며 신고자를 IA(investment adviser)로 식별합니다.

신고서에는 10,011,852주에 대한 단독 의결권과 10,141,066주에 대한 단독 처분권이 명시되어 있으며, 해당 주식이 영업의 정상적인 범위 내에서 보유되고 있고 지배권을 변경하거나 영향력을 행사하기 위한 목적이 아님을 인증하고 있습니다. 이 공시는 5% 보고 기준을 초과하는 수동적이면서 중요한 지분 보유를 투자자에게 알립니다.

Solventum Corporation a reçu une déclaration Schedule 13G de la part d'Independent Franchise Partners, LLP, un conseiller en investissement du Royaume-Uni, déclarant la propriété bénéficiaire de 10 141 066 actions ordinaires, représentant 5,86% de la classe en circulation. Le dépôt couvre les actions ordinaires de l'émetteur et identifie la personne déclarante comme IA (investment adviser).

La déclaration indique un pouvoir de vote exclusif sur 10 011 852 actions et un pouvoir de disposition exclusif sur 10 141 066 actions, et comprend une certification selon laquelle les actions sont détenues dans le cours normal des affaires et non dans le but de changer ou d'influencer le contrôle. La communication informe les investisseurs d'une participation matérielle et passive supérieure au seuil de déclaration de 5%.

Solventum Corporation hat eine Schedule 13G-Meldung von Independent Franchise Partners, LLP, einem Investmentberater aus dem Vereinigten Königreich, erhalten, die die wirtschaftliche Eigentümerschaft von 10.141.066 Stammaktien meldet, was 5,86% der ausstehenden Klasse entspricht. Die Einreichung betrifft die Stammaktien des Emittenten und identifiziert den Melder als IA (investment adviser).

Die Erklärung weist ein alleiniges Stimmrecht für 10.011.852 Aktien und ein alleiniges Verfügungsrecht für 10.141.066 Aktien aus und enthält eine Bestätigung, dass die Aktien im gewöhnlichen Geschäftsgang gehalten werden und nicht mit dem Ziel, die Kontrolle zu ändern oder zu beeinflussen. Die Offenlegung informiert Anleger über eine passive, materielle Beteiligung oberhalb der Meldegrenze von 5%.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



Independent Franchise Partners, LLP
Signature:Sandeep Ghela
Name/Title:Sandeep Ghela | Chief Operating Officer
Date:08/13/2025

FAQ

How many SOLV shares does Independent Franchise Partners report owning?

The filing reports beneficial ownership of 10,141,066 shares of Solventum Corporation common stock.

What percentage of SOLV does that stake represent?

The reported position represents 5.86% of the company’s outstanding common stock.

Does the filer have voting control over the SOLV shares?

Yes. The filer reports sole voting power for 10,011,852 shares and sole dispositive power for 10,141,066 shares.

What type of filer is Independent Franchise Partners for SOLV?

The filing identifies Independent Franchise Partners, LLP as an investment adviser (IA) organized in the United Kingdom.

Does the Schedule 13G indicate intent to influence control of SOLV?

The certification states the securities are held in the ordinary course of business and not for the purpose of changing or influencing control.
Solventum Corporation

NYSE:SOLV

SOLV Rankings

SOLV Latest News

SOLV Latest SEC Filings

SOLV Stock Data

12.50B
138.79M
20%
67.89%
2.23%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
ST. PAUL